DynaMed™
Transcription
DynaMed™
™ e er me , h y An ti s D y na M s e ed Acc DynaMed An y w ™ DynaMed A product of EBSCO Health DynaMed™ is a clinical reference tool created by physicians for physicians and other health care professionals for use at the point-ofcare. With thousands of topics, DynaMed is an indispensable resource for answering clinical questions during practice. DynaMed balances the latest content and resources with validity, relevance and convenience to create the most useful clinical resource possible. Updated daily, DynaMed applies a 7-step systematic evidencebased process to all of its content, assuring that the science backing the conclusions is sound. Why Would I Use DynaMed? • Improve health outcomes and reduce health care costs by using the best available evidence for clinical decision-making How Do I Access DynaMed? You can access DynaMed from workstations throughout your institution and from your mobile device. (Contact your administrator for details about how to take advantage of mobile access.) Use the information below to log in to DynaMed remotely. Access URL: User Name: • Quickly obtain pertinent information right at the point-of-care • Keep abreast of the latest medical research with daily updates through DynaMed’s Systematic Literature Surveillance • Earn Continuing Medical Education (CME) credits Password: Help Contact: Content information on reverse side... Content, Features & Functionality at a Glance... 1 2 3 Easy, Powerful Searching E-Newsletter 6 Mobile Calculators Send Comment Search by keyword or browse alphabetically by specific topic or by category Content in this section is updated frequently to highlight clinically relevant news and information Where Care Comes First Browse: Recent Updates ABCDEFGHIJKLMNOPQRSTUVWXYZ 2 3 EBM Focus Newsletter Sign up for DynaMed’s free newsletter to receive updates on timely and significant changes from “articles most likely to change clinical practice.” Free CME credit is available. Browse Categories Search Other Services • DynaMed shown to be THE MOST CURRENT point-of-care reference (BMJ 2011 Sep 23) • DynaMed 7-Step Evidence-Based Methodology • Introducing Practice Changing Updates • ST-elevation myocardial infarction (STEMI) updated with ESC/ACCF/AHA/WHF 2012 universal definition of MI (Eur Heart J 2012 Oct) • Obstructive sleep apnea (OSA) in children updated with AAP recommendations (Pediatrics 2012 Sep) • Streptococcal pharyngitis updated with IDSA recommendations (Clin Infect Dis 2012 Sep 9) • DYNAMED WEEKLY UPDATE: Regular Aspirin Use After Diagnosis of Colorectal Cancer May Reduce Mortality in Patients with Tumor PIK3CA Mutation Online PERC NRC LEXI-COMP SMART IMAGEBASE Easily navigate to other relevant medical resources directly from DynaMed, including EBSCO databases (subscription required) Quickly view a list of the most recently updated topic summaries ? 4 Spotlight View details on DynaMed’s 7-step editorial process for determining the best available evidence 5 Search 1 Evidence-Based Methodology Search Other Services About Help F First Hospital Content Spotlight 4 6 Home Recent Updates 5 EBSCO Support Site Privacy Policy Terms of Use Copyright © 2012 EBSCO Industries, Inc. All Rights Reserved. Hover Functionality Get C CME for this Topic Linking Navigation Navigate directly to a topic section from the search result list – Related Search Results 12 Send feedback directly to the DynaMed editorial team 13 Search within Text Search for terms within the body text of topic summaries 15 Quickly discern the quality of evidence via easyto-interpret Level of Evidence labels Internal Topic Linking Easily jump to other related sections of a topic via embedded links 16 Full Text Links 17 Tools Access Full Text medical Journals quickly and easily (subscription required). Create email alerts, print and email topic summaries, or generate persistent links to a topic • • • • based on case-control study retrospective study of 15,326 patients > 65 years old admitted to hospital for AAAvs. placebo for mean 2.5 years 3,379 (22%) had ruptured AAA and 11,947 (78%) had intact AAA ACE inhibitor use reported in 665 (20%) with ruptured AAA vs. 2,761 (23%) with intact AAA (odds ratio 0.82, 95% CI 0.74-0.9) • no statistically significant associations found for beta blockers, calcium channel blockers, alpha blockers, angiotensin receptor blockers, or thiazide diuretics • Reference - Lancet 2006 Aug 19;368(9536):659 EBSCOhost Full Text editorial can be found in Lancet Calculators Send Comment About 2006 Aug 19;368(9536):622 EBSCOhost Full Text Am Fam Physician 2006 Nov 15;74(10):1780 Search Other Services E-Newsletter Send Comment to Editor Mobile Search Abdominal aortic aneurysm (AAA) 10 Result List 1 of 16 Follow-up A AA Search within text 13 • Reference - J Vasc Surg 2002 Jan;35(1):72 in J Watch 2002 Mar 15;22(6):46 Treatment Prognosis Collapse All in 12% vs. 9% (p = 0.36) ◦ mortality 14 surgery for AAA in 20% vs. 26% (p = 0.11) ◦ elective of study medication in 42.4% vs. 26.8% (p = 0.0002) ◦ cessation ◦ withdrawal due to adverse effects 38% vs. 21% (NNH 6) ◦ propranolol poorly tolerated and might increase mortality (level 2 [mid-level] evidence) Treatment Overview + + + + Where Care Comes First • comparing propanol vs. placebo + History and Physical + Diagnosis + Medications + Surgery and procedures Expand All • based on small randomized trial with high dropout rate • 54 patients with small AAA diagnosed on screening were randomized to propranolol 40 mg vs. placebo orally twice dailyvs. placebo for mean 2.5 years • comparing propanol vs. placebo 11 Prevention and Screening Quality Improvement in 16.7% vs. 4.2% (relative risk [RR] = 1.6, 95% CI 1.02-2.51) ◦ mortality ◦ dropout rate 60% vs. 25% (RR = 1.74, 95% CI 1.06-2.86) ACE inhibitors: Guidelines and Resources Patient Information ACE inhibitors reported to be associated with reduced risk of ruptured AAA (level 3 [lacking direct] evidence) + ICD-9/ICD-10 Codes + References • • • • based on case-control study retrospective study of 15,326 patients > 65 years old admitted to hospital for AAAvs. placebo for mean 2.5 years 15 (78%) had intact AAA 3,379 (22%) had ruptured AAA and 11,947 ACE inhibitor use reported in 665 (20%) with ruptured AAA vs. 2,761 (23%) with intact AAA (odds ratio 0.82, 95% CI 0.74-0.9) • no statistically significant associations found for beta blockers, calcium channel blockers, alpha blockers, angiotensin receptor blockers, or thiazide diuretics • Reference - Lancet 2006 Aug 19;368(9536):659 EBSCOhost Full Text editorial can be found in Lancet 2006 Aug 19;368(9536):622 EBSCOhost Full Text Am Fam Physician 2006 Nov 15;74(10):1780 Patient Education Reference Center Search Other Services Send Comment to Editor 16 12 Help F First Hospital ? Abdominal aortic aneurysm (AAA) Associated Conditions Level of Evidence Labeling Tools ACE inhibitors reported to be associated with reduced risk of ruptured AAA (level 3 [lacking direct] evidence) Patient Education Reference Center – 14 Guidelines and Resources Patient Information + Related Re Summaries + Ge General Information + Causes and Risk Factors + Complications and 9 in 16.7% vs. 4.2% (relative risk [RR] = 1.6, 95% CI 1.02-2.51) ◦ mortality ◦ dropout rate 60% vs. 25% (RR = 1.74, 95% CI 1.06-2.86) ACE inhibitors: + ICD-9/ICD-10 Codes + References Get C CME for this Topic Search within text • based on small randomized trial with high dropout rate • 54 patients with small AAA diagnosed on screening were randomized to propranolol 40 mg vs. placebo orally twice dailyvs. placebo for mean 2.5 years • comparing propanol vs. placebo Prognosis Comments to the Editor AA ◦ propranolol poorly tolerated and might increase mortality (level 2 [mid-level] evidence) Prevention and Screening Quality Improvement Home Recent Updates A Collapse All in 12% vs. 9% (p = 0.36) ◦ mortality surgery for AAA in 20% vs. 26% (p = 0.11) ◦ elective cessation study medication in 42.4% vs. 26.8% (p = 0.0002) ◦ withdrawalofdue to adverse effects 38% vs. 21% (NNH 6) ◦ Follow-up Navigation Where Care Comes First • Reference - J Vasc Surg 2002 Jan;35(1):72 in J Watch 2002 8 Mar 15;22(6):46 Treatment + Medications + Surgery and procedures + + + + F First Hospital ? Expand All Help • comparing propanol vs. placebo 7 Treatment Overview CME View and select subsections of DynaMed topics for direct access to specific sections 1 of 16 + History and Physical + Diagnosis Earn continuing education credits 11 Result List Associated Conditions View relevant search results from related EBSCO databases (subscription required) 10 Search About Abdominal aortic aneurysm (AAA) + Related Re Summaries + Ge General Information + Causes and Risk Factors + Complications and » 9 Send Comment » 8 Calculators Mobile Abdominal aortic aneurysm (AAA) Hover over a topic to see the full table of contents » 7 E-Newsletter » Home Recent Updates Tools 17 What will I find in DynaMed? One-click access to full-text articles Ability to earn CMEs Alerts when topics are updated Practice changing updates Clinical Calculators Guidelines Easy access from EMRs EBM Focus e-newsletter ICD-9 and ICD-10 codes © EBSCO Industries, Inc. Printed in U.S.A. (1013) EBS-2758
Similar documents
format
• DynaMed shown to be THE MOST CURRENT point-of-care reference (BMJ 2011 Sep 23) • DynaMed 7-Step Evidence-Based Methodology • Introducing Practice Changing Updates • ST-elevation myocardial infarc...
More informationDynaMed Product Brochure
physicians affiliated with world-renowned academic medical centers such as Harvard Medical School and Massachusetts General Hospital. DynaMed’s team of authors and editors are focused on identifyin...
More information